BPMC - BLUEPRINT MEDICINES CORP
This page shows which of the focused investors we track hold BPMC and how their positions changed, so you can see how much conviction the group has in the stock.
In Q1 2021 it was held by 3 managers with an aggregate reported value of $285.24M, which is 0.03% of the combined portfolio.
As of Q1 2021, 3 tracked institutional managers held BPMC (BLUEPRINT MEDICINES CORP) with an aggregate reported value of $285.24M — 0.03% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades BPMC — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q1 2021
- Ticker
- BPMC
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Stephen Mandel - Lone Pine Capital | 0.96% | - | 2,709,138 | $263.41M |
| 2 | Viking Global Investors - Viking Global Investors | 0.06% | Reduce -21.9% | 213,050 | $20.72M |
| 3 | Torray Funds - Torray Funds | 0.17% | New | 11,506 | $1.12M |
Loading holder history for BPMC…